Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
This review by Oliver Philps provides an overview of GLP-1 agonists and where they fit in the treatment of diabetes, how the peptide drugs evolved over time to todays weight loss medications, and what to expect next...
Gajendran M, Sarosiek I, McCallum R (2021) Metoclopramide nasal spray for management of symptoms of acute and recurrent diabetic gastroparesis in adults
Catalent Sector: Drug delivery technologies HQ: Morrisville, NC Year Founded: 2007 Key Leaders: Alessandro Maselli, President and CEO Number of Employees: ~17,000 Stage: Subsidiary of Novo Holdings A/S (private) Financial Snapshot: The market cap was approximately $11.52 billion before the company went private
A research guide with an honest review of the evidence base
US$ 29.27
US$ 23.69
US$ 24.12
US$ 26.32
US$ 29.95
